[1] |
WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali.
Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1209-1218.
|
[2] |
SHAN Hui, DU Yinxiao, BAI Hequn, CHEN Junxia, HE Xiaolin, WANG Qian, HU Zijian, LV Cheng, CHEN Xiaoping.
Progress in the development of baicalein and its clinical pharmacology study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 701-708.
|
[3] |
YANG Di, YUAN Tingting, GAN Shulei, CUI Yajiao, DING Ru, WU Yulin,YANG Jing.
Comparative study on the pharmacokinetics of baicalin and baicalein in rats after intravenous administration
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 394-400.
|
[4] |
YAN Dandan, HUANG Fang, XU Lihua.
Effects of Huashenzilu on chronic eczema in mice model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1358-1363.
|
[5] |
GUO Huixia, TAO Mengqing, ZUO Jian, WANG Weiping.
Microemulsion as the drug delivery system improves inhibitory effects of α-mangostin on synovium
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1227-1231.
|
[6] |
JIN Congcong, WANG Peiyu, LIN Jia, ZHOU Wei, YANG Haiyan.
A comparison of clinical applications of transdermal estradiol and estradiol valerate on endometrial receptivity in frozen-thawed embryo transfer cycles
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(10): 1162-1166.
|
[7] |
YU Wen-ying, ZHANG Liang, CHEN Guo-shen, YE Jin-cui.
Research progress in application of multi-component mixtures of enhancers in transdermal drug delivery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 103-109.
|
[8] |
MAO Jie, SHENG Li-li, XU Shan-shui, WANG Xuan-zhi.
Influence on cell proliferation and invasiveness of human astrocytic glioma cell line SHG-44 by baicalein
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(7): 750-754.
|
[9] |
LI Zhi-ping, LIN Yan-qiong,WANG Hui, LIANG Qing.
Usage of equivalent numerical method based on entropy weight in evaluating comprehensively the promoting effect of transdermal enhancers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(4): 417-422.
|
[10] |
CHEN Yan-fen, WANG Tong-ren, WANG Hui, LIANG Qing.
Evaluation of promoting effects of transdermal enhancers with principle components analysis method
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(7): 788-793.
|
[11] |
MAO Jie, XU Shan-shui, SHEN Li-li, WANG Xuan-zhi.
Advances in the studies on the anti-tumor effect and mechanism of baicalein
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(10): 1178-1182.
|
[12] |
WANG Hui.
Progress in pharmacokinetic of transdermal drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(11): 1216-1220.
|
[13] |
YU Jia, LIANG Wen-quan, JIN Yi.
Studies on permeation of transdermal progesterone delivery system in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 907-910.
|
[14] |
WEN Qing, FENG Kun, GUO Rui-chen.
Study on absorption and distribution of oxybutynin oral tablet and transdermal gel in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(5): 586-589.
|
[15] |
XU Zong-yan, WU Tie, WU Zhi-hua.
Progress in animal model of dermatitis and eczema
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(7): 730-733.
|